Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer.
Yang JC, Xu P, Ning S, Wasielewski LJ, Adomat H, Hwang SH, Morisseau C, Gleave M, Corey E, Gao AC, Lara PN Jr, Evans CP, Hammock BD, Liu C.
Yang JC, et al. Among authors: evans cp.
Oncogene. 2023 Feb;42(9):693-707. doi: 10.1038/s41388-022-02566-6. Epub 2023 Jan 3.
Oncogene. 2023.
PMID: 36596844
Free PMC article.